Risk Factors for E-Cigarette, or Vaping, Product Use–Associated Lung Injury (EVALI) Among Adults Who Use E-Cigarette, or Vaping, Products — Illinois, July–October 2019

• DOI: 10.15585/mmwr.mm6845e1
• Publication Date: 2019-11-08T17:00:30Z
• Authors: Livia Navon; Christopher M. Jones; Isaac Ghinai; Brian A. King; Peter A. Briss; Karen A. Hacker; Jennifer E. Layden
• Keywords: Electronic cigarette

The United States is experiencing an unprecedented outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI) (1). All EVALI patients have used products, and most (≥85%) reported using products containing tetrahydrocannabinol (THC) (2,3), the principal psychoactive component cannabis. To examine whether use behaviors differed between adult adults who these but not developed injury, Illinois Department Public Health (IDPH) conducted online public survey during September-October 2019 targeting users in Illinois. Among 4,631 respondents, 94% any nicotine-containing past 3 months; 21% THC-containing products; 11% both products. Prevalence was highest among respondents aged 18-24 years (36%) decreased with increasing age. E-cigarette, 66 18-44 were interviewed as part ongoing investigation compared a subset 519 Compared had higher odds reporting exclusive (adjusted ratio [aOR] = 2.0, 95% confidence interval [CI] 1.1-3.6); frequent (more than five times per day) (aOR 3.1, CI 1.6-6.0), obtaining from informal sources, such dealer, off street, friend 9.2, 2.2-39.4). Dank Vapes, class largely counterfeit also 8.5, 3.8-19.0). These findings reinforce current recommendations to that contain THC obtained sources. In addition, because specific compound ingredient causing yet known, CDC continues recommend persons consider refraining all while